Ştefănescu B, Călinoiu L, Ranga F, Fetea F, Mocan A, Vodnar D, et al. Chemical Composition and Biological Activities of the Nord-West Romanian Wild Bilberry (Vaccinium myrtillus L.) and Lingonberry (Vaccinium vitis-idaea L.) Leaves. Antioxidants (Basel). 2020;9: pubmed publisher

Zalevskaya O, Gur eva Y, Kutchin A, Hansford K. Antimicrobial and Antifungal Activities of Terpene-Derived Palladium Complexes. Antibiotics (Basel). 2020;9: pubmed publisher

Fakhruddin K, Egusa H, Ngo H, Panduwawala C, Pesee S, Venkatachalam T, et al. Silver diamine fluoride (SDF) used in childhood caries management has potent antifungal activity against oral Candida species. BMC Microbiol. 2020;20:95 pubmed publisher

Alves R, Kastora S, Gomes Gonçalves A, Azevedo N, Rodrigues C, Silva S, et al. Transcriptional responses of Candida glabrata biofilm cells to fluconazole are modulated by the carbon source. NPJ Biofilms Microbiomes. 2020;6:4 pubmed publisher

Celaj A, Gebbia M, Musa L, Coté A, Snider J, Wong V, et al. Highly Combinatorial Genetic Interaction Analysis Reveals a Multi-Drug Transporter Influence Network. Cell Syst. 2020;10:25-38.e10 pubmed publisher

Tanase C, Mocan A, Coșarcă S, Gavan A, Nicolescu A, Gheldiu A, et al. Biological and Chemical Insights of Beech (Fagus sylvatica L.) Bark: A Source of Bioactive Compounds with Functional Properties. Antioxidants (Basel). 2019;8: pubmed publisher

Tullio V, Roana J, Scalas D, Mandras N. Evaluation of the Antifungal Activity of Mentha x piperita (Lamiaceae) of Pancalieri (Turin, Italy) Essential Oil and Its Synergistic Interaction with Azoles. Molecules. 2019;24: pubmed publisher

Ma Q, Ola M, Iracane E, Butler G. Susceptibility to Medium-Chain Fatty Acids Is Associated with Trisomy of Chromosome 7 in Candida albicans. mSphere. 2019;4: pubmed publisher

Hosseini S, Ghaemi E, Noroozi A, Niknejad F. Zinc Oxide Nanoparticles Inhibition of Initial Adhesion and ALS1 and ALS3 Gene Expression in Candida albicans Strains from Urinary Tract Infections. Mycopathologia. 2019;184:261-271 pubmed publisher

Shokry D, Waters L, Parkes G, Mitchell J. Prediction of human intestinal absorption using micellar liquid chromatography with an aminopropyl stationary phase. Biomed Chromatogr. 2019;33:e4515 pubmed publisher

Demuyser L, Van Dyck K, Timmermans B, Van Dijck P. Inhibition of Vesicular Transport Influences Fungal Susceptibility to Fluconazole. Antimicrob Agents Chemother. 2019;63: pubmed publisher

Kočendová J, Vaňková E, Volejníková A, Nešuta O, Budesinsky M, Socha O, et al. Antifungal activity of analogues of antimicrobial peptides isolated from bee venoms against vulvovaginal Candida spp. FEMS Yeast Res. 2019;19: pubmed publisher

Gao J, Wang H, Li Z, Wong A, Wang Y, Guo Y, et al. Candida albicans gains azole resistance by altering sphingolipid composition. Nat Commun. 2018;9:4495 pubmed publisher

Scalas D, Mandras N, Roana J, Tardugno R, Cuffini A, Ghisetti V, et al. Use of Pinus sylvestris L. (Pinaceae), Origanum vulgare L. (Lamiaceae), and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible Cryptococcus neoformans str. BMC Complement Altern Med. 2018;18:143 pubmed publisher

Prasad H, Rao R. Histone deacetylase-mediated regulation of endolysosomal pH. J Biol Chem. 2018;293:6721-6735 pubmed publisher

Waters L, Shokry D, Parkes G, Mitchell J. The Use of Bile Salt Micelles for the Prediction of Human Intestinal Absorption. J Pharm Sci. 2016;105:3611-3614 pubmed publisher

Peralta M, da Silva M, Ortega M, Cabrera J, Paraje M. Usnic Acid Activity on Oxidative and Nitrosative Stress of Azole-Resistant Candida albicans Biofilm. Planta Med. 2017;83:326-333 pubmed publisher

Furlan S, Watkins B, Tkachev V, Flynn R, Cooley S, Ramakrishnan S, et al. Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention. Sci Transl Med. 2015;7:315ra191 pubmed publisher

Shrestha S, Fosso M, Garneau Tsodikova S. A combination approach to treating fungal infections. Sci Rep. 2015;5:17070 pubmed publisher

Abadio A, Kioshima E, Leroux V, Martins N, Maigret B, Felipe M. Identification of New Antifungal Compounds Targeting Thioredoxin Reductase of Paracoccidioides Genus. PLoS ONE. 2015;10:e0142926 pubmed publisher

Gonzalez J, Rodriguez C, Zuluaga A, Agudelo M, Vesga O. Demonstration of Therapeutic Equivalence of Fluconazole Generic Products in the Neutropenic Mouse Model of Disseminated Candidiasis. PLoS ONE. 2015;10:e0141872 pubmed publisher

Badran A, Liu D. Development of potent in vivo mutagenesis plasmids with broad mutational spectra. Nat Commun. 2015;6:8425 pubmed publisher

Salazar Aranda R, Granados Guzmán G, Pérez Meseguer J, Gonzalez G, de Torres N. Activity of Polyphenolic Compounds against Candida glabrata. Molecules. 2015;20:17903-12 pubmed publisher

Chen J, Yu X, Zhou Y, Zhang Y, Zhu J, Xie L, et al. Integrated measures for prevention of invasive Candida infections in preterm infants in a Chinese neonatal intensive care unit. Am J Infect Control. 2015;43:1321-5 pubmed publisher

Brilhante R, Rodrigues P, de Alencar L, Riello G, Ribeiro J, de Oliveira J, et al. Evidence of Fluconazole-Resistant Candida Species in Tortoises and Sea Turtles. Mycopathologia. 2015;180:421-6 pubmed publisher

Cordeiro R, Serpa R, Marques F, de Melo C, Evangelista A, Mota V, et al. Inhibitory activity of isoniazid and ethionamide against Cryptococcus biofilms. Can J Microbiol. 2015;61:827-36 pubmed publisher

Mazzarino M, Cesarei L, de la Torre X, Fiacco I, Robach P, Botrè F. A multi-targeted liquid chromatography-mass spectrometry screening procedure for the detection in human urine of drugs non-prohibited in sport commonly used by the athletes. J Pharm Biomed Anal. 2016;117:47-60 pubmed publisher

García R, Botet J, Rodríguez Peña J, Bermejo C, Ribas J, Revuelta J, et al. Genomic profiling of fungal cell wall-interfering compounds: identification of a common gene signature. BMC Genomics. 2015;16:683 pubmed publisher

Brezina E, Prasse C, Wagner M, Ternes T. Why Small Differences Matter: Elucidation of the Mechanisms Underlying the Transformation of 2OH- and 3OH-Carbamazepine in Contact with Sand Filter Material. Environ Sci Technol. 2015;49:10449-56 pubmed publisher

Ouf S, El Adly A, Mohamed A. Inhibitory effect of silver nanoparticles mediated by atmospheric pressure air cold plasma jet against dermatophyte fungi. J Med Microbiol. 2015;64:1151-1161 pubmed publisher

Abu Darwish M, Cabral C, Gonçalves M, Cavaleiro C, Cruz M, Efferth T, et al. Artemisia herba-alba essential oil from Buseirah (South Jordan): Chemical characterization and assessment of safe antifungal and anti-inflammatory doses. J Ethnopharmacol. 2015;174:153-60 pubmed publisher

Luna Tapia A, Peters B, Eberle K, Kerns M, Foster T, Marrero L, et al. ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis. Eukaryot Cell. 2015;14:1006-16 pubmed publisher

Irimie M, Oantă A, Irimie C, Minea D. Prevalence and antifungal susceptibility patterns of dermatophytes isolated from patients with neoplastic diseases: a case control study. Acta Dermatovenerol Croat. 2015;23:108-13 pubmed

Feng X, Ling B, Yang X, Liao W, Pan W, Yao Z. Molecular Identification of Candida Species Isolated from Onychomycosis in Shanghai, China. Mycopathologia. 2015;180:365-71 pubmed publisher

Rossmann J, Gurke R, Renner L, Oertel R, Kirch W. Evaluation of the matrix effect of different sample matrices for 33 pharmaceuticals by post-column infusion. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;1000:84-94 pubmed publisher

Zubrická D, Mišianiková A, Henzelyová J, Valletta A, De Angelis G, D Auria F, et al. Xanthones from roots, hairy roots and cell suspension cultures of selected Hypericum species and their antifungal activity against Candida albicans. Plant Cell Rep. 2015;34:1953-62 pubmed publisher

Chen Y, Chang T, Liu J, Chen F, Chien C, Lee C, et al. Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study. BMC Infect Dis. 2015;15:277 pubmed publisher

Yazdanparast S, Khodavaisy S, Fakhim H, Shokohi T, Haghani I, Nabili M, et al. Molecular Characterization of Highly Susceptible Candida africana from Vulvovaginal Candidiasis. Mycopathologia. 2015;180:317-23 pubmed publisher

Brosh Nissimov T, Ben Ami R. Differential association of fluconazole dose and dose/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection. Clin Microbiol Infect. 2015;21:1011-7 pubmed publisher

Pattanawongsa A, Chau N, Rowland A, Miners J. Inhibition of Human UDP-Glucuronosyltransferase Enzymes by Canagliflozin and Dapagliflozin: Implications for Drug-Drug Interactions. Drug Metab Dispos. 2015;43:1468-76 pubmed publisher

Moreira A, Silva S, Botelho C, Sampaio P, Pais C, Henriques M. Candida bracarensis: Evaluation of Virulence Factors and its Tolerance to Amphotericin B and Fluconazole. Mycopathologia. 2015;180:305-15 pubmed publisher

Wani M, Ahmad A, Shiekh R, Al Ghamdi K, Sobral A. Imidazole clubbed 1,3,4-oxadiazole derivatives as potential antifungal agents. Bioorg Med Chem. 2015;23:4172-80 pubmed publisher

Kawai A, Yamagishi Y, Mikamo H. In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms. J Infect Chemother. 2015;21:647-53 pubmed publisher

da Silva B, Silva L, de Oliveira D, da Silva P, Ferreira Paim K, Andrade Silva L, et al. Species Distribution, Virulence Factors, and Antifungal Susceptibility Among Candida parapsilosis Complex Isolates Recovered from Clinical Specimens. Mycopathologia. 2015;180:333-43 pubmed publisher

Garvey E, Hoekstra W, Schotzinger R, Sobel J, Lilly E, Fidel P. Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasis. Antimicrob Agents Chemother. 2015;59:5567-73 pubmed publisher

Packer J, Naz T, Harrington D, Jamie J, Vemulpad S. Antimicrobial activity of customary medicinal plants of the Yaegl Aboriginal community of northern New South Wales, Australia: a preliminary study. BMC Res Notes. 2015;8:276 pubmed publisher

Mor V, Rella A, Farnoud A, Singh A, Munshi M, Bryan A, et al. Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids. MBio. 2015;6:e00647 pubmed publisher

Chitescu C, Kaklamanos G, Nicolau A, Stolker A. High sensitive multiresidue analysis of pharmaceuticals and antifungals in surface water using U-HPLC-Q-Exactive Orbitrap HRMS. Application to the Danube river basin on the Romanian territory. Sci Total Environ. 2015;532:501-11 pubmed publisher

El Gohary N, Shaaban M. Synthesis, Antimicrobial, Antiquorum-Sensing, and Cytotoxic Activities of New Series of Isoindoline-1,3-dione, Pyrazolo[5,1-a]isoindole, and Pyridine Derivatives. Arch Pharm (Weinheim). 2015;348:666-80 pubmed publisher

Caggiano G, Coretti C, Bartolomeo N, Lovero G, De Giglio O, Montagna M. Candida Bloodstream Infections in Italy: Changing Epidemiology during 16 Years of Surveillance. Biomed Res Int. 2015;2015:256580 pubmed publisher

Sharifzadeh A, Khosravi A, Shokri H, Sharafi G. Antifungal effect of Trachyspermum ammi against susceptible and fluconazole-resistant strains of Candida albicans. J Mycol Med. 2015;25:143-50 pubmed publisher

Shi C, Liu C, Liu J, Wang Y, Li J, Xiang M. Anti-Candida Activity of New Azole Derivatives Alone and in Combination with Fluconazole. Mycopathologia. 2015;180:203-7 pubmed publisher

Santos N, Mariane B, Lago J, Sartorelli P, Rosa W, Soares M, et al. Assessing the Chemical Composition and Antimicrobial Activity of Essential Oils from Brazilian Plants-Eremanthus erythropappus (Asteraceae), Plectrantuns barbatus, and P. amboinicus (Lamiaceae). Molecules. 2015;20:8440-52 pubmed publisher

Lum K, Tay S, Le C, Lee V, Sabri N, Velayuthan R, et al. Activity of Novel Synthetic Peptides against Candida albicans. Sci Rep. 2015;5:9657 pubmed publisher

Kırmızıbekmez H, Uysal G, Masullo M, Demirci F, Bağcı Y, Kan Y, et al. Prenylated polyphenolic compounds from Glycyrrhiza iconica and their antimicrobial and antioxidant activities. Fitoterapia. 2015;103:289-93 pubmed publisher

Li Z, Guo X, Dawuti G, Aibai S. Antifungal Activity of Ellagic Acid In Vitro and In Vivo. Phytother Res. 2015;29:1019-25 pubmed publisher

Li T, Zhu Y, Fan S, Liu X, Xu H, Liang Y. A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis. Med Mycol. 2015;53:455-61 pubmed publisher

Li X, Cai Q, Mei H, Zhou X, Shen Y, Li D, et al. The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans. J Antimicrob Chemother. 2015;70:1993-2003 pubmed publisher

O Meara T, Veri A, Ketela T, Jiang B, Roemer T, Cowen L. Global analysis of fungal morphology exposes mechanisms of host cell escape. Nat Commun. 2015;6:6741 pubmed publisher

Kathuria S, Singh P, Sharma C, Prakash A, Masih A, Kumar A, et al. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek . J Clin Microbiol. 2015;53:1823-30 pubmed publisher

Andrade T, De Lima S, Freitas R, Rocha M, Islam T, da Silva T, et al. Isolation, characterization and evaluation of antimicrobial and cytotoxic activity of estragole, obtained from the essential oil of Croton zehntneri (Euphorbiaceae). An Acad Bras Cienc. 2015;87:173-82 pubmed publisher

El Gohary N, Shaaban M. Antimicrobial and antiquorum-sensing studies. Part 3: Synthesis and biological evaluation of new series of [1,3,4]thiadiazoles and fused [1,3,4]thiadiazoles. Arch Pharm (Weinheim). 2015;348:283-97 pubmed publisher

Guo B, Fang Z, Yang L, Xiao L, Xia Y, Gonzalez F, et al. Tissue and species differences in the glucuronidation of glabridin with UDP-glucuronosyltransferases. Chem Biol Interact. 2015;231:90-7 pubmed publisher

Zhang M, Liu X, Jin Y, Jiang D, Wei X, Xie H. Lamellar keratoplasty treatment of fungal corneal ulcers with acellular porcine corneal stroma. Am J Transplant. 2015;15:1068-75 pubmed publisher

Liu J, Shi C, Wang Y, Li W, Zhao Y, Xiang M. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China. Res Microbiol. 2015;166:153-61 pubmed publisher

Hashemi S, Badali H, Irannejad H, Shokrzadeh M, Emami S. Synthesis and biological evaluation of fluconazole analogs with triazole-modified scaffold as potent antifungal agents. Bioorg Med Chem. 2015;23:1481-91 pubmed publisher

Dong D, Li Z, Zhang L, Jiang C, Mao E, Wang X, et al. Clinical and microbiological investigation of fungemia from four hospitals in China. Mycopathologia. 2015;179:407-14 pubmed publisher

Pereira C, de Oliveira D, Hughes A, Kohlhoff M, LA Vieira M, Martins Vaz A, et al. Endophytic fungal compounds active against Cryptococcus neoformans and C. gattii. J Antibiot (Tokyo). 2015;68:436-44 pubmed publisher

Arisoy M, Temiz Arpaci O, Kaynak Onurdağ F, Ozgen S. Synthesis and antimicrobial evaluation of 2-(p-substituted phenyl)-5-[(4-substituted piperazin-l-yl)acetamido]-benzoxazoles. Z Naturforsch C J Biosci. 2014;69:368-74 pubmed

Khan M, Aljarbou A, Khan A, Younus H. Liposomal thymoquinone effectively combats fluconazole-resistant Candida albicans in a murine model. Int J Biol Macromol. 2015;76:203-8 pubmed publisher

Jakab A, Emri T, Sipos L, Kiss A, Kovacs R, Dombradi V, et al. Betamethasone augments the antifungal effect of menadione--towards a novel anti-Candida albicans combination therapy. J Basic Microbiol. 2015;55:973-81 pubmed publisher

Luna Tapia A, Kerns M, Eberle K, Jursic B, Palmer G. Trafficking through the late endosome significantly impacts Candida albicans tolerance of the azole antifungals. Antimicrob Agents Chemother. 2015;59:2410-20 pubmed publisher

Iyer R, Ferrari A, Rijnbrand R, Erwin A. A fluorescent microplate assay quantifies bacterial efflux and demonstrates two distinct compound binding sites in AcrB. Antimicrob Agents Chemother. 2015;59:2388-97 pubmed publisher

Basso L, Gast C, Bruzual I, Wong B. Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans. J Antimicrob Chemother. 2015;70:1396-407 pubmed publisher

Krashin E, Lishner M, Chowers M, Reisfeld S. Candida albicans in peritoneal fluid in a patient with hepatic encephalopathy. Isr Med Assoc J. 2014;16:801-2 pubmed

Manzoor S, Buffon R, Rossi A. Molecularly imprinted solid phase extraction of fluconazole from pharmaceutical formulations. Talanta. 2015;134:1-7 pubmed publisher

Rodrigues C, Silva S, Azeredo J, Henriques M. Detection and quantification of fluconazole within Candida glabrata biofilms. Mycopathologia. 2015;179:391-5 pubmed publisher

Chen M, Zhai L, Arendrup M. In vitro activity of 23 tea extractions and epigallocatechin gallate against Candida species. Med Mycol. 2015;53:194-8 pubmed publisher

Mehta P, Justo L, Walsh S, Arshad M, Wilson C, O Sullivan C, et al. New platforms for multi-functional ocular lenses: engineering double-sided functionalized nano-coatings. J Drug Target. 2015;23:305-10 pubmed publisher

Pinder N, Zimmermann J, Hofer S, Brenner T, Weigand M, Gubbe U, et al. Revival of physostigmine - a novel HPLC assay for simultaneous determination of physostigmine and its metabolite eseroline designed for a pharmacokinetic study of septic patients. Clin Chem Lab Med. 2015;53:1259-64 pubmed publisher

Brazzola G, Chèvre N, Wedekind C. Additive genetic variation for tolerance to estrogen pollution in natural populations of Alpine whitefish (Coregonus sp., Salmonidae). Evol Appl. 2014;7:1084-93 pubmed publisher

Al Hatmi A, Van Diepeningen A, Curfs Breuker I, de Hoog G, Meis J. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex. J Antimicrob Chemother. 2015;70:1068-71 pubmed publisher

Sung A, Marcella S, Xie Y. An update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United States. J Med Econ. 2015;18:341-8 pubmed publisher

Trabasso P, Matsuzawa T, Fagnani R, Muraosa Y, Tominaga K, Resende M, et al. Isolation and drug susceptibility of Candida parapsilosis sensu lato and other species of C. parapsilosis complex from patients with blood stream infections and proposal of a novel LAMP identification method for the species. Mycopathologia. 2015;179:53-62 pubmed publisher

Xiao M, Fan X, Chen S, Wang H, Sun Z, Liao K, et al. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance. J Antimicrob Chemother. 2015;70:802-10 pubmed publisher

Silva R, Sridhar J, Miller D, Wykoff C, Flynn H. Exogenous fungal endophthalmitis: an analysis of isolates and susceptibilities to antifungal agents over a 20-year period (1990-2010). Am J Ophthalmol. 2015;159:257-64.e1 pubmed publisher

Bouzabata A, Cabral C, Gonçalves M, Cruz M, Bighelli A, Cavaleiro C, et al. Myrtus communis L. as source of a bioactive and safe essential oil. Food Chem Toxicol. 2015;75:166-72 pubmed publisher

Rawal M, Shokoohinia Y, Chianese G, Zolfaghari B, Appendino G, Taglialatela Scafati O, et al. Jatrophanes from Euphorbia squamosa as potent inhibitors of Candida albicans multidrug transporters. J Nat Prod. 2014;77:2700-6 pubmed publisher

Udy A, Jarrett P, Stuart J, Lassig Smith M, Starr T, Dunlop R, et al. Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds. Crit Care. 2014;18:657 pubmed publisher

Kong E, Kucharíková S, Van Dijck P, Peters B, Shirtliff M, Jabra Rizk M. Clinical implications of oral candidiasis: host tissue damage and disseminated bacterial disease. Infect Immun. 2015;83:604-13 pubmed publisher

Fan S, Liu X, Wu C, Xu L, Li J. Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis. Mycopathologia. 2015;179:95-101 pubmed publisher

Oertel B, Huynh T, Hummel T, Lotsch J. Lack of fluconazole effects on human chemosensation. Int J Clin Pharmacol Ther. 2015;53:13-20 pubmed publisher

Kucharíková S, Neirinck B, Sharma N, Vleugels J, Lagrou K, Van Dijck P. In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model. J Antimicrob Chemother. 2015;70:846-56 pubmed publisher

Santos J, Holanda R, Frases S, Bravim M, Araujo G, Santos P, et al. Fluconazole alters the polysaccharide capsule of Cryptococcus gattii and leads to distinct behaviors in murine Cryptococcosis. PLoS ONE. 2014;9:e112669 pubmed publisher

Koehling H, Willinger B, Buer J, Rath P, Steinmann J. Comparative evaluation of a new commercial colorimetric microdilution assay (SensiQuattro Candida EU) with MIC test strip and EUCAST broth microdilution methods for susceptibility testing of invasive Candida isolates. J Clin Microbiol. 2015;53:255-61 pubmed publisher

Day J, Imran D, Ganiem A, Tjahjani N, Wahyuningsih R, Adawiyah R, et al. CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial. Trials. 2014;15:441 pubmed publisher

Schneider S, Morschhäuser J. Induction of Candida albicans drug resistance genes by hybrid zinc cluster transcription factors. Antimicrob Agents Chemother. 2015;59:558-69 pubmed publisher

Li H, Chen Z, Zhang C, Gao Y, Zhang X, Sun S. Resistance reversal induced by a combination of fluconazole and tacrolimus (FK506) in Candida glabrata. J Med Microbiol. 2015;64:44-52 pubmed publisher

Hu L, Du X, Li T, Song Y, Zai S, Hu X, et al. Genetic and phenotypic characterization of Candida albicans strains isolated from infectious disease patients in Shanghai. J Med Microbiol. 2015;64:74-83 pubmed publisher

Pansieri C, Pandolfini C, Jacqz Aigrain E, van den Anker J, Bonati M. Fluconazole prophylaxis in neonates. Arch Dis Child. 2015;100:75-6 pubmed publisher

Charoo N, Cristofoletti R, Graham A, Lartey P, Abrahamsson B, Groot D, et al. Biowaiver monograph for immediate-release solid oral dosage forms: fluconazole. J Pharm Sci. 2014;103:3843-3858 pubmed publisher

McMullen R, Gilger B, Michau T. Modified lamellar keratoplasties for the treatment of deep stromal abscesses in horses. Vet Ophthalmol. 2015;18:393-403 pubmed publisher

Satyanarayan A, Klotz S, Han L, Sobonya R, Zangeneh T. Coccidioidomycosis of the genitourinary tract: a case report and discussion. Urology. 2014;84:e30-1 pubmed publisher

Noonan J, Dusting G, Nguyen T, Jenkins A, Man R, Best W, et al. Flicker light-induced retinal vasodilation is unaffected by inhibition of epoxyeicosatrienoic acids and prostaglandins in humans. Invest Ophthalmol Vis Sci. 2014;55:7007-13 pubmed publisher

Katragkou A, McCarthy M, Alexander E, Antachopoulos C, Meletiadis J, Jabra Rizk M, et al. In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms. J Antimicrob Chemother. 2015;70:470-8 pubmed publisher

Abbes S, Amouri I, Sellami H, Neji S, Trabelsi H, Cheikhrouhou F, et al. Changes in genotype and fluconazole susceptibility of isolates from patients with Candida glabrata in Tunisia. Therapie. 2014;69:449-55 pubmed publisher

Stachowicz J, Krajewska Kułak E, Lukaszuk C, Niewiadomy A. Relationship between Antifungal Activity against Candida albicans and Electron Parameters of Selected N-Heterocyclic Thioamides. Indian J Pharm Sci. 2014;76:287-98 pubmed

Chowdhary A, Kathuria S, Singh P, Sharma B, Dolatabadi S, Hagen F, et al. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India. Mycoses. 2014;57 Suppl 3:97-107 pubmed publisher

Minea B, Năstasă V, Moraru R, Kolecka A, Flonta M, Marincu I, et al. Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study. Eur J Clin Microbiol Infect Dis. 2015;34:367-83 pubmed publisher

Fortin A, Caridha D, Leed S, Ngundam F, Sena J, Bosschaerts T, et al. Direct comparison of the efficacy and safety of oral treatments with oleylphosphocholine (OlPC) and miltefosine in a mouse model of L. major cutaneous leishmaniasis. PLoS Negl Trop Dis. 2014;8:e3144 pubmed publisher

Tian X, Liang S, Wang C, Wu B, Ge G, Deng S, et al. Regioselective glucuronidation of andrographolide and its major derivatives: metabolite identification, isozyme contribution, and species differences. AAPS J. 2015;17:156-66 pubmed publisher

Brilhante R, de Jesus Santos Rodrigues T, de Souza Collares Maia Castelo Branco D, Teixeira C, de Brito Macedo R, Bandeira S, et al. Antifungal susceptibility and virulence attributes of animal-derived isolates of Candida parapsilosis complex. J Med Microbiol. 2014;63:1568-72 pubmed publisher

Sławiński J, Pogorzelska A, Zołnowska B, Kedzia A, Ziółkowska Klinkosz M, Kwapisz E. Synthesis and anti-yeast evaluation of novel 2-alkylthio-4-chloro-5-methyl-N-[imino-(1-oxo-(1H)-phthalazin-2-yl)methyl]benzenesulfonamide derivatives. Molecules. 2014;19:13704-23 pubmed publisher

Zhao W, Le Guellec C, Benjamin D, Hope W, Bourgeois T, Watt K, et al. First dose in neonates: are juvenile mice, adults and in vitro-in silico data predictive of neonatal pharmacokinetics of fluconazole. Clin Pharmacokinet. 2014;53:1005-18 pubmed publisher

van der Elst K, Pereboom M, van den Heuvel E, Kosterink J, Schölvinck E, Alffenaar J. Insufficient fluconazole exposure in pediatric cancer patients and the need for therapeutic drug monitoring in critically ill children. Clin Infect Dis. 2014;59:1527-33 pubmed publisher

Oertel B, Vermehren J, Huynh T, Doehring A, Ferreirós N, Zimmermann M, et al. Cytochrome P450 epoxygenase dependence of opioid analgesia: fluconazole does not interfere with remifentanil-mediated analgesia in human subjects. Clin Pharmacol Ther. 2014;96:684-93 pubmed publisher

Anil S, Hashem M, Vellappally S, Patil S, Bandara H, Samaranayake L. Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals. Mycopathologia. 2014;178:207-15 pubmed publisher

Ramos L, Figueiredo Carvalho M, Barbedo L, Ziccardi M, Chaves A, Zancope Oliveira R, et al. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil. J Antimicrob Chemother. 2015;70:111-5 pubmed publisher

Mohamed G, Ibrahim S, Shaaban M, Ross S. Mangostanaxanthones I and II, new xanthones from the pericarp of Garcinia mangostana. Fitoterapia. 2014;98:215-21 pubmed publisher

Hempstead J, Clode A, Borst L, Gilger B. Histopathological features of equine superficial, nonhealing, corneal ulcers. Vet Ophthalmol. 2014;17 Suppl 1:46-52 pubmed

Wang H, Zrada M, Anderson K, Katwaru R, Harradine P, Choi B, et al. Understanding and reducing the experimental variability of in vitro plasma protein binding measurements. J Pharm Sci. 2014;103:3302-9 pubmed publisher

Dinger J, Meyer M, Maurer H. Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse. Toxicol Lett. 2014;230:28-35 pubmed publisher

Yang Y, Chen M, Gu J, Zhu F, Xu X, Zhang C, et al. Cryptococcosis in kidney transplant recipients in a Chinese university hospital and a review of published cases. Int J Infect Dis. 2014;26:154-61 pubmed publisher

Reis de Sá L, Toledo F, de Sousa B, Gonçalves A, Tessis A, Wendler E, et al. Synthetic organotelluride compounds induce the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisiae. BMC Microbiol. 2014;14:201 pubmed publisher

Chavez Dozal A, Lown L, Jahng M, Walraven C, Lee S. In vitro analysis of finasteride activity against Candida albicans urinary biofilm formation and filamentation. Antimicrob Agents Chemother. 2014;58:5855-62 pubmed publisher

Pankey G, Ashcraft D, Kahn H, Ismail A. Time-kill assay and Etest evaluation for synergy with polymyxin B and fluconazole against Candida glabrata. Antimicrob Agents Chemother. 2014;58:5795-800 pubmed publisher

Sonawane P, Cho H, Tagde A, Verlekar D, Yu A, Reynolds C, et al. Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma. Br J Pharmacol. 2014;171:5330-44 pubmed publisher

Gamarra S, Morano S, Dudiuk C, Mancilla E, Nardin M, de Los Angeles Méndez E, et al. Epidemiology and antifungal susceptibilities of yeasts causing vulvovaginitis in a teaching hospital. Mycopathologia. 2014;178:251-8 pubmed publisher

Zhang J, Liu J, Liu F, Xia Y, Wang J, Liu X, et al. Vulvovaginal candidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression. Mycoses. 2014;57:584-91 pubmed

Barnes K, Rowland A, Polasek T, Miners J. Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins. Eur J Clin Pharmacol. 2014;70:1097-106 pubmed publisher

Ramírez Zavala B, Mogavero S, Schöller E, Sasse C, Rogers P, Morschhäuser J. SAGA/ADA complex subunit Ada2 is required for Cap1- but not Mrr1-mediated upregulation of the Candida albicans multidrug efflux pump MDR1. Antimicrob Agents Chemother. 2014;58:5102-10 pubmed publisher

Jiang L, Yong X, Li R, Peng Y, Liu W, Qin Q, et al. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China. J Oral Pathol Med. 2014;43:696-703 pubmed publisher

Rahman A, Murrow J, Ozkor M, Kavtaradze N, Lin J, De Staercke C, et al. Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans. J Vasc Res. 2014;51:200-8 pubmed publisher

Kan C, Singh A, Stafforini D, Azhar S, Liu J. Arachidonic acid downregulates acyl-CoA synthetase 4 expression by promoting its ubiquitination and proteasomal degradation. J Lipid Res. 2014;55:1657-67 pubmed publisher

Whaley S, Caudle K, Vermitsky J, Chadwick S, Toner G, Barker K, et al. UPC2A is required for high-level azole antifungal resistance in Candida glabrata. Antimicrob Agents Chemother. 2014;58:4543-54 pubmed publisher

Neto J, da Silva C, Neta M, Campos R, Siebra J, Silva R, et al. Antifungal activity of naphthoquinoidal compounds in vitro against fluconazole-resistant strains of different Candida species: a special emphasis on mechanisms of action on Candida tropicalis. PLoS ONE. 2014;9:e93698 pubmed publisher

Gao Y, Li H, Liu S, Zhang X, Sun S. Synergistic effect of fluconazole and doxycycline against Candida albicans biofilms resulting from calcium fluctuation and downregulation of fluconazole-inducible efflux pump gene overexpression. J Med Microbiol. 2014;63:956-961 pubmed publisher

Benjamin D, Hudak M, Duara S, Randolph D, Bidegain M, Mundakel G, et al. Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial. JAMA. 2014;311:1742-9 pubmed publisher

Guo H, Xie S, Li S, Song Y, Lv X, Zhang H. Synergistic mechanism for tetrandrine on fluconazole against Candida albicans through the mitochondrial aerobic respiratory metabolism pathway. J Med Microbiol. 2014;63:988-996 pubmed publisher

Cordeiro R, Macedo R, Teixeira C, Marques F, Bandeira T, Moreira J, et al. The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex. J Med Microbiol. 2014;63:936-944 pubmed publisher

Sharma C, Muralidhar S, Xu J, Meis J, Chowdhary A. Multilocus sequence typing of Candida africana from patients with vulvovaginal candidiasis in New Delhi, India. Mycoses. 2014;57:544-52 pubmed publisher

Selvaraj M, Pandurangan P, Ramasami N, Rajendran S, Sangilimuthu S, Perumal P. Highly potential antifungal activity of quantum-sized silver nanoparticles against Candida albicans. Appl Biochem Biotechnol. 2014;173:55-66 pubmed publisher

Mistretta V, Dubois N, Denooz R, Charlier C. Simultaneous determination of seven azole antifungal drugs in serum by ultra-high pressure liquid chromatography and diode array detection. Acta Clin Belg. 2014;69:53-61 pubmed publisher

Zhao Y, Wang B, Zhang S, Yang S, Wang H, Ren A, et al. Isolation of antifungal compound from Paeonia suffruticosa and its antifungal mechanism. Chin J Integr Med. 2015;21:211-6 pubmed publisher

Curvelo J, Marques A, Barreto A, Romanos M, Portela M, Kaplan M, et al. A novel nerolidol-rich essential oil from Piper claussenianum modulates Candida albicans biofilm. J Med Microbiol. 2014;63:697-702 pubmed publisher

Teixeira K, Denadai A, Sinisterra R, Cortés M. Cyclodextrin modulates the cytotoxic effects of chlorhexidine on microrganisms and cells in vitro. Drug Deliv. 2015;22:444-53 pubmed publisher

Chang Y, Hung S, Liu C, Hsu H, Chao P, Lee F, et al. Cryptococcal infection of the vocal folds. Southeast Asian J Trop Med Public Health. 2013;44:1043-6 pubmed

Chen Y, Yu S, Huang H, Chang Y, Lehman V, Silao F, et al. Calcineurin controls hyphal growth, virulence, and drug tolerance of Candida tropicalis. Eukaryot Cell. 2014;13:844-54 pubmed publisher

Shigemura K, Osawa K, Jikimoto T, Yoshida H, Hayama B, Ohji G, et al. Comparison of the clinical risk factors between Candida albicans and Candida non-albicans species for bloodstream infection. J Antibiot (Tokyo). 2014;67:311-4 pubmed publisher

Pemmaraju S, Pruthi P, Prasad R, Pruthi V. Candida albicans biofilm inhibition by synergistic action of terpenes and fluconazole. Indian J Exp Biol. 2013;51:1032-7 pubmed

Zhang X, Zhang G, Wang Z, Guo H, Gao L, Wu S, et al. Proteomic analysis reveals that Adh1p is involved in a synergistic fluconazole and tetrandrine mechanism against Candida albicans. Pharmazie. 2013;68:951-4 pubmed

Mishra N, Ali S, Shukla P. Arachidonic acid affects biofilm formation and PGE2 level in Candida albicans and non-albicans species in presence of subinhibitory concentration of fluconazole and terbinafine. Braz J Infect Dis. 2014;18:287-93 pubmed publisher

Nelson S, Vytopil M. Recurrence of coccidioidal meningitis after discontinuation of fluconazole. JAMA Neurol. 2013;70:1586 pubmed publisher

Mølgaard Nielsen D, Pasternak B, Hviid A. Oral fluconazole during pregnancy and risk of birth defects. N Engl J Med. 2013;369:2061-2 pubmed publisher

Sgherri C, Porta A, Castellano S, Pinzino C, Quartacci M, Calucci L. Effects of azole treatments on the physical properties of Candida albicans plasma membrane: a spin probe EPR study. Biochim Biophys Acta. 2014;1838:465-73 pubmed publisher

. Oral fluconazole and vulvovaginal candidiasis: prevention is not always better than cure. Prescrire Int. 2013;22:205 pubmed

Pan J, Zhang N, Jin Y, Ye Z, Ma M, Cai X, et al. Pulmonary cryptococcosis presenting as wandering multiple bilateral shadows and hilar and mediastinal lymph node enlargement in the lungs. Trop Doct. 2013;43:144-7 pubmed publisher

Biesbroek J, Verduyn Lunel F, Kragt J, Amelink G, Frijns C. Culture-negative Candida meningitis diagnosed by detection of Candida mannan antigen in CSF. Neurology. 2013;81:1555-6 pubmed publisher

Fukuda T. [Prophylaxis and treatment for invasive fungal infection: update]. Rinsho Ketsueki. 2013;54:1932-9 pubmed

Nevitt B, Langan J, Adkesson M, Delaney M, Rubin D, Muhlbauer M, et al. Multifocal Cryptococcus neoformans var. neoforms: infection, treatment, and monitoring by serial computed tomography in a Schmidt's red-tailed guenon (Cercopithecus ascanius schmidti). J Zoo Wildl Med. 2013;44:728-36 pubmed

Spilk S, Herr M, Sinoway L, Leuenberger U. Endothelium-derived hyperpolarizing factor contributes to hypoxia-induced skeletal muscle vasodilation in humans. Am J Physiol Heart Circ Physiol. 2013;305:H1639-45 pubmed publisher

Khan A, Khurshid M, Tawfik A. In vitro evaluation of vincristine and fluconazole combination against Candida. Pak J Pharm Sci. 2013;26:1037-40 pubmed

Alothman A, Al Musawi T, Al Abdely H, Salman J, Almaslamani M, Yared N, et al. Clinical practice guidelines for the management of invasive Candida infections in adults in the Middle East region: Expert panel recommendations. J Infect Public Health. 2014;7:6-19 pubmed publisher

Prevost N, English J. Candida rib osteomyelitis: erythema and nodule in midline scar. J Am Acad Dermatol. 2013;69:e205-7 pubmed publisher

Nyilasi I, Kocsubé S, Krizsán K, Galgoczy L, Papp T, Pesti M, et al. Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations. Med Mycol. 2014;52:140-8 pubmed

Mølgaard Nielsen D, Pasternak B, Hviid A. Use of oral fluconazole during pregnancy and the risk of birth defects. N Engl J Med. 2013;369:830-9 pubmed publisher

Mohammed N, Rejinold N, Mangalathillam S, Biswas R, Nair S, Jayakumar R. Fluconazole loaded chitin nanogels as a topical ocular drug delivery agent for corneal fungal infections. J Biomed Nanotechnol. 2013;9:1521-31 pubmed

Garcia J, Soch K, Matthew E, Surani S, Horseman M. Endocarditis caused by Candida dubliniensis. Am J Med Sci. 2013;346:237-9 pubmed publisher

Fesharaki S, Haghani I, Mousavi B, Kargar M, Boroumand M, Anvari M, et al. Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser. J Med Microbiol. 2013;62:1763-1767 pubmed publisher

Demiraslan H, Alabay S, Kiliç A, Borlu M, Doganay M. Cutaneous candidiasis caused by Candida glabrata in a HIV/AIDS patient. Int J STD AIDS. 2013;24:753-5 pubmed publisher

Molepo J, Musenge E. Clade-related phenotypic switching among fluconazole resistant Candida albicans isolates. SADJ. 2012;67:326-8 pubmed

Bertz H, Drognitz K, Lubbert M. No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation. Ann Hematol. 2014;93:165-7 pubmed publisher

Shen Y, Huang X, Wang J, Jin J, Hu J, Yu K, et al. Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study. Int J Clin Pharmacol Ther. 2013;51:738-45 pubmed publisher

Kotb E, Anwar M, Abbas H, Abd El Moez S. A concise synthesis and antimicrobial activity of a novel series of naphthylpyridine-3-carbonitrile compounds. Acta Pol Pharm. 2013;70:667-79 pubmed

Pfaller M, Diekema D, Procop G, Rinaldi M. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values. Diagn Microbiol Infect Dis. 2013;77:37-40 pubmed publisher

Akhtar S, Masood S, Tabassum S, Rizvi D. Efficacy of itraconazole versus fluconazole in vaginal candidiasis. J Pak Med Assoc. 2012;62:1049-52 pubmed

Schillig R, Morschhäuser J. Analysis of a fungus-specific transcription factor family, the Candida albicans zinc cluster proteins, by artificial activation. Mol Microbiol. 2013;89:1003-17 pubmed publisher

Villagrana Zesati J, Guerra Infante F, Sosa González I. [Clinical efficacy of fluconazole, tinidazole and clindamycin vs fluconazole, tinidazole and azithromycin in the treatment of mixed cervical-vaginal infections, included those caused by Mycoplasma and Chlamydia trachomatis]. Ginecol Obstet Mex. 2013;81:231-8 pubmed

Osawa K, Shigemura K, Yoshida H, Fujisawa M, Arakawa S. Candida urinary tract infection and Candida species susceptibilities to antifungal agents. J Antibiot (Tokyo). 2013;66:651-4 pubmed publisher

Tamura K, Inoue K, Takahashi M, Matsuo S, Irie K, Kodama Y, et al. Dose-response involvement of constitutive androstane receptor in mouse liver hypertrophy induced by triazole fungicides. Toxicol Lett. 2013;221:47-56 pubmed publisher

Zaouak A, Badri T, Zaiem A, Ben Jennet S, Fenniche S, Mokhtar I. Cutaneous pigmented patches. Presse Med. 2013;42:1152-4 pubmed publisher

Wysham N, Sullivan D, Allada G. An opportunistic infection associated with ruxolitinib, a novel janus kinase 1,2 inhibitor. Chest. 2013;143:1478-1479 pubmed publisher

Belofsky G, Kolaczkowski M, Adams E, Schreiber J, Eisenberg V, Coleman C, et al. Fungal ABC transporter-associated activity of isoflavonoids from the root extract of Dalea formosa. J Nat Prod. 2013;76:915-25 pubmed publisher

Menachery J, Chawla Y, Chakrabarti A, Duseja A, Dhiman R, Kalra N. Fungal liver abscess in an immunocompetent individual. Trop Gastroenterol. 2012;33:232-3 pubmed

Ding Y, Fang H. Edematous erythema, subcutaneous plaques, and severe pain in the lower extremities in an immunocompromised patient. JAMA. 2013;309:1632-3 pubmed publisher

Hellfritzsch M, Lassen P, Nielsen L. [Severe neurotoxicological reaction by combined treatment with vincristine and fluconazole]. Ugeskr Laeger. 2013;175:1042-3 pubmed

. Treating cryptococcal meningitis in people with HIV. BMJ. 2013;346:f2203 pubmed publisher

Czaika V, Lam P. Trichophyton mentagrophytes cause underestimated contagious zoophilic fungal infection. Mycoses. 2013;56 Suppl 1:33-7 pubmed publisher

Menezes E, Vasconcelos Júnior A, Angelo M, Cunha M, Cunha F. Correlation between microdilution, Etest, and disk diffusion methods for antifungal susceptibility testing of fluconazole against Candida sp. blood isolates. Rev Soc Bras Med Trop. 2013;46:106-7 pubmed

Bogum J, Faust D, Zühlke K, Eichhorst J, Moutty M, Furkert J, et al. Small-molecule screening identifies modulators of aquaporin-2 trafficking. J Am Soc Nephrol. 2013;24:744-58 pubmed publisher

Austin N, Darlow B, McGuire W. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. Cochrane Database Syst Rev. 2013;:CD003478 pubmed publisher

Dylag M, Lis P, Niedźwiecka K, Ko Y, Pedersen P, Goffeau A, et al. 3-Bromopyruvate: a novel antifungal agent against the human pathogen Cryptococcus neoformans. Biochem Biophys Res Commun. 2013;434:322-7 pubmed publisher

Ferreira A, Prado C, Carvalho R, Dias K, Dias A. Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections. Mycopathologia. 2013;175:265-72 pubmed publisher

Nucci M, Queiroz Telles F, Alvarado Matute T, Tiraboschi I, Cortes J, Zurita J, et al. Epidemiology of candidemia in Latin America: a laboratory-based survey. PLoS ONE. 2013;8:e59373 pubmed publisher

Sasai D, Okubo Y, Ishiwatari T, Sugita T, Kaneko T, Murayama S, et al. Histopathological evaluation of the efficacy of antifungals for experimental Trichosporon bloodstream infection. Jpn J Infect Dis. 2013;66:133-9 pubmed

Sarma S, Kumar N, Sharma S, Govil D, Ali T, Mehta Y, et al. Candidemia caused by amphotericin B and fluconazole resistant Candida auris. Indian J Med Microbiol. 2013;31:90-1 pubmed publisher

Dreyfuss D, Ricard J, Gaudry S. Amphotericin B deoxycholate for candidiasis in intensive care unit patients revisited: medical, ethical, and financial implications. Am J Respir Crit Care Med. 2013;187:661-3 pubmed

Camacho Gonzalez A, Spearman P, Stoll B. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am. 2013;60:367-89 pubmed publisher

Agut A, Boza S, Murciano J, Belda E, Soler M. What is your diagnosis? Cryptococcal patellar osteomyelitis. J Am Vet Med Assoc. 2013;242:745-7 pubmed publisher

Ramli S, Leong M, Khaithir T, Aziz M, Loons L, Rafia M. Cryptococcus humicolus meningitis: first case report in Malaysia. Southeast Asian J Trop Med Public Health. 2012;43:1212-7 pubmed

Kakuda T, Van Solingen Ristea R, Aharchi F, Smedt G, Witek J, Nijs S, et al. Pharmacokinetics and short-term safety of etravirine in combination with fluconazole or voriconazole in HIV-negative volunteers. J Clin Pharmacol. 2013;53:41-50 pubmed publisher

Turaka K, Gordon A, Patel S, Bryan J, Kwong H, Dugel P, et al. Diagnostic and therapeutic challenges. Retina. 2013;33:661-5 pubmed publisher

Chadwick S, Schuyler J, Vermitsky J, Adelson M, Mordechai E, Gygax S. X-Plate Technology: a new method for detecting fluconazole resistance in Candida species. J Med Microbiol. 2013;62:720-726 pubmed publisher

Meyer A, Kendi C, Penner J, Odhiambo N, Otieno B, Omondi E, et al. The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in Kenya. Trop Med Int Health. 2013;18:495-503 pubmed publisher

da Silva C, de Andrade Neto J, Sidrim J, Angelo M, Magalhães H, Cavalcanti B, et al. Synergistic effects of amiodarone and fluconazole on Candida tropicalis resistant to fluconazole. Antimicrob Agents Chemother. 2013;57:1691-700 pubmed publisher

Knoth H, Petry T, Gartner P. Differential pulse polarographic investigation of the antifungal drugs itraconazole, ketoconazole, fluconazole and voriconazole using a dropping mercury electrode. Pharmazie. 2012;67:987-90 pubmed

Bean L, Jackson J, Dobak W, Beiswenger T, Thorp J. Intra-amniotic fluconazole therapy for Candida albicans intra-amniotic infection. Obstet Gynecol. 2013;121:452-4 pubmed publisher

Egunsola O, Adefurin A, Fakis A, Jacqz Aigrain E, Choonara I, Sammons H. Safety of fluconazole in paediatrics: a systematic review. Eur J Clin Pharmacol. 2013;69:1211-21 pubmed publisher

Liu X, Wu M, Peng Y, Chen X, Sun J, Huang F, et al. Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study. Cell Transplant. 2014;23:1087-98 pubmed publisher

Rosa M, Silva B, Pires P, Silva N, Silva F, Souza S, et al. Weekly fluconazole therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2013;167:132-6 pubmed publisher

Chen W, Liou S, Tzeng T, Lee S, Liu I. Wound repair and anti-inflammatory potential of Lonicera japonica in excision wound-induced rats. BMC Complement Altern Med. 2012;12:226 pubmed publisher

Nakai N, Katoh N. Fixed drug eruption caused by fluconazole: a case report and mini-review of the literature. Allergol Int. 2013;62:139-41 pubmed publisher

Pai V, Bhandari P, Kikkeri N, Athanikar S, Sori T. Fixed drug eruption to fluconazole: a case report and review of literature. Indian J Pharmacol. 2012;44:643-5 pubmed publisher

Cheong J, McCormack J. Fluconazole resistance in cryptococcal disease: emerging or intrinsic?. Med Mycol. 2013;51:261-9 pubmed publisher

Blyth C, Barzi F, Hale K, Isaacs D. Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin. J Paediatr Child Health. 2012;48:846-51 pubmed publisher

Turner K, Manzoni P, Benjamin D, Cohen Wolkowiez M, Smith P, Laughon M. Fluconazole pharmacokinetics and safety in premature infants. Curr Med Chem. 2012;19:4617-20 pubmed

Gupta A, Drummond Main C, Paquet M. Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment. J Dermatolog Treat. 2013;24:75-80 pubmed publisher

Castagnola E, Jacqz Aigrain E, Kaguelidou F, Maragliano R, Stronati M, Rizzollo S, et al. Fluconazole use and safety in the nursery. Early Hum Dev. 2012;88 Suppl 2:S11-5 pubmed publisher

Ethier M, Science M, Beyene J, Briel M, Lehrnbecher T, Sung L. Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysi. Br J Cancer. 2012;106:1626-37 pubmed publisher

Sinnollareddy M, Peake S, Roberts M, Playford E, Lipman J, Roberts J. Pharmacokinetic evaluation of fluconazole in critically ill patients. Expert Opin Drug Metab Toxicol. 2011;7:1431-40 pubmed publisher

Smego R, AHMAD H. The role of fluconazole in the treatment of Candida endocarditis: a meta-analysis. Medicine (Baltimore). 2011;90:237-49 pubmed publisher

Venisse N, Le Guellec C. [Level of evidence for therapeutic drug monitoring of fluconazole]. Therapie. 2011;66:97-101 pubmed

Lee J, Jang E, Han Y. Combination immunotherapy of MAb B6.1 with fluconazole augments therapeutic effect to disseminated candidiasis. Arch Pharm Res. 2011;34:399-405 pubmed publisher

Cooper J, Hwang K, Singh H, Wang D, Reynolds C, Curley R, et al. Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposure. Br J Pharmacol. 2011;163:1263-75 pubmed publisher

Pietrella D, Angiolella L, Vavala E, Rachini A, Mondello F, Ragno R, et al. Beneficial effect of Mentha suaveolens essential oil in the treatment of vaginal candidiasis assessed by real-time monitoring of infection. BMC Complement Altern Med. 2011;11:18 pubmed publisher

Pfaller M, Andes D, Diekema D, Espinel Ingroff A, Sheehan D. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Updat. 2010;13:180-95 pubmed publisher

Thiyanaratnam J, Cohen P, Powell S. Fluconazole-associated Stevens-Johnson syndrome. J Drugs Dermatol. 2010;9:1272-5 pubmed

Wilkerson J, McPherson C, Donze A. Fluconazole to prevent systemic fungal infections in infants: reviewing the evidence. Neonatal Netw. 2010;29:323-33 pubmed

Kothavade R, Kura M, Valand A, Panthaki M. Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. J Med Microbiol. 2010;59:873-80 pubmed publisher

Kaufman D. Epidemiology and prevention of neonatal candidiasis: fluconazole for all neonates?. Adv Exp Med Biol. 2010;659:99-119 pubmed publisher

Kelesidis T, Tsiodras S. Candida albicans prosthetic hip infection in elderly patients: is fluconazole monotherapy an option?. Scand J Infect Dis. 2010;42:12-21 pubmed publisher

Reed B, Caudle K, Rogers P. Fluconazole prophylaxis in high-risk neonates. Ann Pharmacother. 2010;44:178-84 pubmed publisher

Arendrup M, Kahlmeter G, Rodriguez Tudela J, Donnelly J. Breakpoints for susceptibility testing should not divide wild-type distributions of important target species. Antimicrob Agents Chemother. 2009;53:1628-9 pubmed publisher

Schumacher J, de Larrinoa I, Tudzynski B. Calcineurin-responsive zinc finger transcription factor CRZ1 of Botrytis cinerea is required for growth, development, and full virulence on bean plants. Eukaryot Cell. 2008;7:584-601 pubmed publisher

Uppuluri P, Nett J, Heitman J, Andes D. Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob Agents Chemother. 2008;52:1127-32 pubmed publisher